Panel Discussion: Supercharging Oncology Therapeutics with Unprecedented Patient Surveillance to Provide Insights On Risk of Relapse & Improve Survival
Time: 3:45 pm
day: Day One
Details:
- Leveraging MRD to act as a biomarker for patient relapse
- Developing surrogate endpoints using ctDNA
- Investigating the potential of multi-markers in advancing patient monitoring
